<DOC>
	<DOCNO>NCT00772564</DOCNO>
	<brief_summary>The administration high dose HMG-CoA reductase inhibitor ( Statins ) patient acute ST-elevation MI ( hypoxia/ischemia ) treat primary PCI ( reoxygenation/ reperfusion ) protect cardiomyocytes death thus preserve LV ejection fraction .</brief_summary>
	<brief_title>The Use Statins Myocardial Death Prevention</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Patients suffer acute ST elevation result myocardial infarction , Killip Classification 1 2 include atrandom either group . Included subject able give inform consent participate study . 1 . The impossibility give require informed consent . 2 . Known allergy Atorvastatin . 3 . Base line serum creatinine 1.4 mg/dL . 4 . Killip Classification 3 4 . 5 . Persisting vomit . 6 . History previous liver disease . 7 . History previous muscle disease rabdomyolisis . 8 . Treated already high dose atorvastatin 9 . Non Compliance .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Acute ST Elevation Myocardial Infarction</keyword>
</DOC>